JPMA Urges Drug Makers To Establish Pandemic Guidelines Amid Flu Infections
This article was originally published in PharmAsia News
Executive Summary
Japan Pharmaceutical Manufacturers Association is urging member companies to establish flu pandemic guidelines. The drug makers' trade association found that out of 60 member companies that responded to a recent survey, 40 have established such guidelines, and JPMA urged quick action for the remaining companies. The recent domestic flu infections in Japan has prompted many drug companies to take measures such as reducing sales visits to hospitals. (Click here for more - Japanese language